TYK Medicines Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Net Income	-	-386.96	-382.43	-310.99
Depreciation & Amortization	-	29.32	27.64	16.33
Other Amortization	-	27.23	8	-
Loss (Gain) From Sale of Assets	-	-0.04	0.01	0.04
Loss (Gain) From Sale of Investments	-	0	0.73	-0.34
Stock-Based Compensation	-	12.47	3.89	-
Other Operating Activities	-	63.32	90.17	76.57
Change in Accounts Receivable	-	-46.49	-11.27	-19.6
Change in Accounts Payable	-	-7.11	62.32	-4.89
Change in Other Net Operating Assets	-	-	-	22.83
Operating Cash Flow	-	-308.25	-200.94	-220.05
Capital Expenditures	-	-73.62	-76.38	-58.97
Sale of Property, Plant & Equipment	-	5.01	0.07	0
Divestitures	-	10	-	-
Sale (Purchase) of Intangibles	-	-	-0.88	-29.21
Investment in Securities	-	-52.74	149.03	-64.15
Other Investing Activities	-	-24.51	1.17	-5.84
Investing Cash Flow	-	-135.86	73.01	-158.17
Short-Term Debt Issued	-	154.15	-	-
Total Debt Issued	-	154.15	-	-
Short-Term Debt Repaid	-	-10.12	-	-
Long-Term Debt Repaid	-	-10.36	-16.48	-1.61
Total Debt Repaid	-	-20.48	-16.48	-1.61
Net Debt Issued (Repaid)	-	133.67	-16.48	-1.61
Issuance of Common Stock	-	580.68	185	325
Repurchase of Common Stock	-	-13.75	-	-
Other Financing Activities	-	-68.52	55.47	27.75
Financing Cash Flow	-	632.08	224	351.14
Foreign Exchange Rate Adjustments	-	0.25	0.01	-
Net Cash Flow	-	188.22	96.07	-27.08
Free Cash Flow	-	-381.87	-277.32	-279.02
Free Cash Flow Margin	-	-356891.59%	-	-630.67%
Free Cash Flow Per Share	-	-1.13	-0.96	-1.00
Cash Interest Paid	-	3.31	-	-
Levered Free Cash Flow	-	-1,455	94.34	-
Unlevered Free Cash Flow	-	-1,447	99.8	-
Change in Working Capital	-	-53.6	51.05	-1.66

Source: S&P Capital IQ. Standard template. Financial Sources.